Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

May 31, 2018

Par Pharmaceutical, Inc. et al v. Eagle Pharmaceuticals, Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 31, 2021

    Endo Unit Loses Trial To Stop Launch Of Vasostrict Generic

    After a three-day bench trial, Delaware's chief federal judge ruled Tuesday that an Endo International unit could not stop the launch of a generic version of blood pressure medication Vasostrict because Endo's newer patents covering the blockbuster drug wouldn't be infringed.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login